Stockreport

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers [Yahoo! Finance]

Alpha Tau Medical Ltd. - Ordinary Shares  (DRTS) 
PDF Initial response data demonstrated an overall response rate of almost 100% in treated lesions and a complete response rate of With follow up as long as 51 months ( me [Read more]